Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 677 press releases before 2019
-
AstraZeneca enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan
-
IRESSA approved by US FDA for first-line treatment of patients with advanced EGFR mutation-positive non-small cell lung cancer
-
AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma for Entocort
-
AstraZeneca and the University of Cambridge announce new joint PhD and clinical research scholarships
-
AstraZeneca to collaborate with Inserm in Type 2 Diabetes and Chronic Kidney Disease studies
-
AstraZeneca to collaborate with the University of Michigan to advance treatments for Chronic Kidney Disease
-
AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
-
AstraZeneca reveals findings of archaeological dig as build gets underway at Cambridge Biomedical Campus
-
New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin compared with sitagliptin
-
AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformin for the treatment of type 2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
